| |
Generative AI has the potential to accelerate innovations across the value chain, from R&D to commercialization. Watch this webinar series to learn why nine out of the top 10 biopharma organizations use AWS for machine learning and analytics. Watch now.
|
|
Today’s Big NewsAug 29, 2023 |
|
Government Biotechnology Innovation Summit Convenes September 27-28 in National Harbor, MD. Hear from government leaders at the forefront on how biotechnology is transforming the economic, agricultural, healthcare and security landscape of the U.S. Learn more.
|
|
| By Fraiser Kansteiner The drugs that made the cut for the first price negotiations are Johnson & Johnson’s Imbruvica, Stelara and Xarelto plus Bristol Myers Squibb’s Eliquis, Merck & Co.’s Januvia, Novartis’ Entresto, Eli Lilly’s Jardiance, AstraZeneca’s Farxiga, Novo Nordisk’s Fiasp and Amgen’s Enbrel. |
|
|
|
By Nick Paul Taylor LIB Therapeutics has passed another milestone on its path to launching a challenger to cholesterol drugs sold by Amgen, Regeneron and Sanofi. In the latest phase 3 readout, the private biotech’s subcutaneous PCSK9 inhibitor cut levels of LDL cholesterol to maintain momentum going into the final two data drops. |
By Andrea Park After spending the better part of the last decade defending itself from claims that it knowingly sold defective earplugs to the U.S. military, resulting in thousands of reports of hearing loss among service members, 3M has reached a settlement in a far-reaching class-action lawsuit over the matter. |
By Angus Liu GLP-1 agonists such as Novo Nordisk’s semaglutide and SGLT2 inhibitors like AstraZeneca’s Farxiga are already bumping heads in diabetes treatment. AstraZeneca’s biopharma business president, Ruud Dobber, said he’s not concerned about a potential upcoming clash between the two classes in heart failure. |
|
Wednesday, September 6, 2023 | 2:00 PM ET / 11:00 AM PT Attendees will learn about the latest tools for interacting with medical images, how to guide readers through labeling workflows, and streamlining adjudication and data standardization. Discussions will include real-world use cases of how pharma companies are enhancing AI development by optimizing reader workflows. Register now.
|
|
By Max Bayer A group of activist investors is once again taking on AIM Immunotech's leadership, suing the company for changes to its bylaws made earlier this year. The company rejected three board nominations earlier this month. |
By Andrea Park In recent years, electrocardiogram technology has become increasingly widely available, embedded into dedicated portable devices, smartwatches and, now, even bathroom scales. |
By Zoey Becker The first-line anemia use in MDS represents a key milestone as Bristol Myers targets $4 billion in peak sales for the new medicine. |
By Annalee Armstrong This year's Fierce 15 features companies pushing the envelope not only in the lab, in the clinic or on the conference circuit. |
By James Waldron While it continues to hone in on the cause of a rare side effect linked to its geographic atrophy drug Syfovre, Apellis has decided to lay off a quarter of its workforce and cull its two preclinical assets to claw back $300 million in savings. |
By Conor Hale The company hopes to turn the type of technology that underpins programs such as ChatGPT toward synthetic biology by training models on genomic and protein data instead of internet images or the written word. |
Fierce podcastsDon’t miss an episode |
| This week on "The Top Line," we discuss the trends seen at Cannes Lions, the top compensated CEOs in the industry, and the cancer drug shortage |
|
|---|
|
|
| WhitepaperLearn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Sponsored by: Thermo Fisher Scientific Process Liquid Preparation Services |
| WhitepaperIn oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| ResearchLearn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| WebinarDownload this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
| |
|
